Drug Database
Back to search

United States· US:0310-9420_cea076d0-c827-4c46-9b36-418bf63d5a9d

WAINUA

A eplontersen product containing eplontersen, registered in United States by AstraZeneca Pharmaceuticals LP. The same ATC class is registered in 13 of our 19 countries.

ATC N07XX21US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedWAINUAATCN07XX21REGISTER NO.US:0310-9420_cea076d0…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eplontersenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eplontersen is registered in 13 of 19 countries.

Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search eplontersen products by name

Eplontersen · ATC N07XX21

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EPLONTERSEN
Manufacturer
AstraZeneca Pharmaceuticals LP
Country
United States (US)
ATC code
N07XX21
ATC class
Eplontersen
Defined daily dose
1.5 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0310942001
    1 SYRINGE, GLASS in 1 CARTON (0310-9420-01) / .8 mL in 1 SYRINGE, GLASS
  • ndc11
    0310-9420-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Eplontersen in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eplontersen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9dca904e-ce17-4469-9529-a413f491d4cc
GET /v1/drugs/9dca904e-ce17-4469-9529-a413f491d4cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "45",
  "substance": "EPLONTERSEN",
  "productndc": "0310-9420",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/.8mL",
  "application_number": "NDA217388",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about eplontersen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console